Ingersoll-Rand (IR) May Benefit From Recovery in Commercial Construction
Get Alerts IR Hot Sheet
Price: $74.00 +1.09%
Rating Summary:
17 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
17 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
Analysts at MKM Partners think Ingersoll-Rand (NYSE: IR) guidance shows progress with the company's long term turnaround story. In their view, the turnaround will be aided by a recovery in commercial construction.
"We believe valuation will continue to expand over time as investors view IR as having best-in-class earnings leverage in a commercial recovery, conservative guidance that could ultimate drive beats and raises through the year and a developing track record of delivering on margin expansion goals," said analyst Joshua Pokrzywinski.
MKM Partners today reiterated a Buy on Ingersoll-Rand and raised its price target to $60.00 (from $55.00).
For an analyst ratings summary and ratings history on Ingersoll-Rand (NYSE: IR) click here. For more ratings news on Ingersoll-Rand click here.
Shares of Ingersoll-Rand closed at $52.36 yesterday.
"We believe valuation will continue to expand over time as investors view IR as having best-in-class earnings leverage in a commercial recovery, conservative guidance that could ultimate drive beats and raises through the year and a developing track record of delivering on margin expansion goals," said analyst Joshua Pokrzywinski.
MKM Partners today reiterated a Buy on Ingersoll-Rand and raised its price target to $60.00 (from $55.00).
For an analyst ratings summary and ratings history on Ingersoll-Rand (NYSE: IR) click here. For more ratings news on Ingersoll-Rand click here.
Shares of Ingersoll-Rand closed at $52.36 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital
- BofA Securities Starts Dollarama Inc. (DOL:CN) (DLMAF) at Buy
- Glenmark Pharmaceuticals Ltd. (GNP:IN) PT Raised to INR2,750 at Investec
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share